GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

Descubre

Tu librería

Busca

For Creators

Tus podcasts

Empieza gratis

Noticias de productos

Nuestra plataforma

Registrate

Nuestra plataforma

Configuración

Tema claro

Tema oscuro

Sigue

Contactos

Información

mostra más

In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership.

We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis.

For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums

mostra menos

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

Sigue

Teclistamab, Talquetamab, and Elranatamab: Response Rates and Data

10 MAY. 2024 · Dr. Sridevi Rajeeve discusses the unprecedented response rates in patients treated with teclistamab, talquetamab, and elranatamab, as well as their clinical trial data.

6m 2s
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma

3 MAY. 2024 · Dr. Tycel Phillips examines the efficacy of two medications against diffuse large b-cell lymphoma (DLBCL)

3m 1s
Barriers to Biomarker Testing: Cost and Insurance

27 ABR. 2024 · Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.

3m 29s
Barriers to Biomarker Testing: Ordering Tests

20 ABR. 2024 · Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC

6m 22s
The Adaura Trial: The Effect on EGFR+ Treatment

15 ABR. 2024 · Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.

6m 25s
Biomarker Driven Therapy for NSCLC

13 ABR. 2024 · Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.

5m 12s
Current Recommendations and Best Practices for Biomarker Testing

11 ABR. 2024 · Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.

3m 52s
The Importance of Biomarker Testing: What is Liquid Biopsy?

9 ABR. 2024 · Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.

4m 54s
Biomarkers in NSCLC

9 ABR. 2024 · Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.

5m 54s
Key Points from the Adaura Trial: Osimertinib

30 NOV. 2023 · Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.

6m 13s